Results 81 to 90 of about 38,988 (220)

Bridging the Gap Between General and Transplant Infectious Disease Practice

Transplant Infectious Disease, EarlyView.
ABSTRACT The population of iatrogenic immunocompromised individuals is steadily rising as we continue to improve in our ability to manage diseases, including cancer, autoimmune disease, and end‐organ dysfunction, with increasing access to novel agents and transplantation.
Jeremey Walker, Emily Eichenberger, Steven Pergam, Maricar Malinis, Andrea J. Zimmer   +4 more
wiley   +1 more source

Limited asymptomatic carriage of Pneumocystis jiroveci in human immunodeficiency virus-infected patients

, 2003
Forty-seven bronchoalveolar lavage fluid samples from 16 human immunodeficiency virus (HIV)-infected patients were used to test the latency model of Pneumocystis infection in the human host.
Denis, CM, Wakefield, AE, Ambrose, HE, Lindley, AR, Miller, RF   +4 more
core  

Acquired Immunodeficiency from Maternal Chemotherapy and Severe Primary Pneumocystis Infection in an Infant

, 2020
Pneumocystis jirovecii is recognized as an opportunistic pathogen in immunosuppressed patients. We report a case of severe Pneumocystis pneumonia (PCP) in an infant with acquired combined immunodeficiency secondary to maternal chemotherapy exposure ...
Julia Elizabeth Clark, Clark, Julia Elizabeth, Alberto Pinzon-Charry, Alphonso, Nelson, Nitin Kapur, Mattke, Adrian Christian, Kapur, Nitin, Adeline Yi Ling Lim, Adrian Christian Mattke, Lim, Adeline Yi Ling, Pinzon-Charry, Alberto, Nelson Alphonso   +11 more
core   +1 more source

Optimizing Pneumocystis jirovecii Prophylaxis in Immunocompromised Patients: Defining the Clinical Role of Atovaquone

Transplant Infectious Disease, EarlyView.
In a retrospective cohort study of 149 patients receiving atovaquone for PJP prophylaxis, increased usage was related to broader indications, uptake in new patient groups, difficulty tolerating or accessing alternatives, and longer durations used per patient.
To N. Pham, Kelly A. Cairns, Adithi Ramachandra, Susan G. Poole, Carmela E. Corallo, Bradley J. Gardiner   +5 more
wiley   +1 more source

Pneumocystis species, co-evolution and pathogenic power

, 2008
International audienceThe genus Pneumocystis comprises uncultured, highly diversified microfungal organisms able to attach specifically to type-1 alveolar epithelial cells and to proliferate in pulmonary alveoli provoking severe pneumonitis.
Dei-Cas, Eduardo, Eric Viscogliosi, Guillot, Jacques, Demanche, Christine, Delhaes, Laurence, Eduardo Dei-Cas, Viscogliosi, Eric, Cécile-Marie Aliouat-Denis, Magali Chabé, Jacques Guillot, Aliouat-Denis, Cécile-Marie, Aliouat, El Moukhtar, El Moukhtar Aliouat, Christine Demanche, Chabe, Magali, Laurence Delhaes   +15 more
core   +1 more source

Axenic Long-Term Cultivation of Pneumocystis jirovecii

, 2023
Pneumocystis jirovecii, a fungus causing severe Pneumocystis pneumonia (PCP) in humans, has long been described as non-culturable. Only isolated short-term experiments with P.
Marie Mahnkopf, Daniel Misch, Hartmut Stocker, Marcus Frank, Hortense Slevogt, Cristina Zubiria-Barrera, Jan Heise, Kristina Wicht, Diana Riebold, Torsten Bauer   +9 more
core   +1 more source

Toxoplasmosis Beyond Transplantation: Diagnostic and Prevention Challenges in a Patient Receiving Targeted Immunomodulators

Transplant Infectious Disease, EarlyView.
ABSTRACT Toxoplasmosis has long been recognized as a serious complication in immunocompromised host, particularly those with advanced HIV/AIDS, hematopoietic stem‐cell transplantation (HSCT), solid‐organ transplant (SOT), and hematological malignancies. The rapid expansion of targeted immunomodulators, including chimeric antigen receptor T‐cell (CAR‐T)
Joy Mouanes‐Abelin, Christelle Pomares, José G. Montoya, Morgane Pondrom, Lucille DE MARIA, Andrea J. Zimmer, Carlos A. Gomez   +6 more
wiley   +1 more source

Human Immmunodeficiency Virus Infection Related Pneumocystis Jiroveci Pneumonia and Suicide: An Autopsy Case Report

, 2016
Pneumocystis jiroveci is the most common and serious opportunistic infection in acquired immune deficiency syndrome patients. It is detected in approximately 80% of human immunodeficiency virus (HIV) infected individuals. In this paper, we present a case
Muzaffer Yıldırım, Taner Daş, Aytül Sargan, Ahmet Selçuk Gürler, Gülhan Yağmur, Cumhur Selçuk Topal, Murat Nihat Arslan, Gökhan Umut, Hızır Aslıyüksek   +8 more
core   +1 more source

Development of Highly Efficient Universal Pneumocystis Primers and Their Application in Investigating the Prevalence and Genetic Diversity of Pneumocystis in Wild Hares and Rabbits

Journal of Fungi
Despite its ubiquitous infectivity to mammals with strong host specificity, our current knowledge about Pneumocystis has originated from studies of merely 4% of extant mammalian species. Further studies of Pneumocystis epidemiology across a broader range
Liang Ma, Isabella Lin, Summer T. Hunter, Barbara Blasi, Patrizia Danesi, Christiane Weissenbacher-Lang, Ousmane H. Cisse, Jamie L. Rothenburger, Joseph A. Kovacs   +8 more
doaj   +1 more source

Sirolimus for Extracranial Arteriovenous Malformations: A Scoping Review of the Evidence in Syndromic and Non‐Syndromic Cases

Pediatric Blood &Cancer, Volume 73, Issue 7, July 2026.
ABSTRACT Arteriovenous malformations (AVMs) are rare, high‐flow, vascular anomalies that can occur either sporadically or as part of a genetic syndrome. AVMs can progress with serious morbidity and even mortality if left unchecked. Sirolimus is an mTOR inhibitor that is effective in low‐flow vascular malformations; however, its role in AVMs is unclear.
Will Swansson, Ingrid Winship, Gary Hammerschlag, Laura Scardamaglia   +3 more
wiley   +1 more source